Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma.

Anna Myriam Perrone,Camelia Alexandra Coada,Gloria Ravegnini,Antonio De Leo,Giuseppe Damiano,Eugenia De Crescenzo,Marco Tesei,Stella Di Costanzo,Lucia Genovesi,Daniela Rubino,Claudio Zamagni,Pierandrea De Iaco

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society（2023）

引用 2|浏览14

暂无评分

摘要

Increasing the number of neoadjuvant chemotherapy cycles does not worsen patient outcomes if complete resection is achieved. Nevertheless, additional prospective trials are necessary to establish the optimum number of neoadjuvant chemotherapy cycles.

查看译文

关键词

neoadjuvant chemotherapy,carcinoma,post-operative

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要